Rich production media as a platform for CHO cell line development

被引:0
|
作者
Yong Jae Kim
Sang Kyul Han
Seongtae Yoon
Chan Wha Kim
机构
[1] Korea University,Department of Biotechnology, College of Life Sciences and Biotechnology
[2] GC Pharma R &D Center,undefined
[3] GC Pharma,undefined
来源
AMB Express | / 10卷
关键词
Cell line development; Chemically defined media; Single cell isolation; Semi-solid media; Chinese hamster ovary cell;
D O I
暂无
中图分类号
学科分类号
摘要
Recent cell culture media for mammalian cells can be abundantly formulated with nutrients supporting production, but such media can be limited to use in host cell culture, transfection, cell cloning, and cell growth under the low cell density conditions. In many cases, appropriate platform media are used for cell line development, and then replaced with rich media for production. In this study, we demonstrate rich chemically defined media for Chinese hamster ovary (CHO) cells that are suitable as basal media both for cell line development and for final production of culture process. Set up for transfection, semi-solid media optimization, mini-pool screening, and single cell cloning media development were performed, and final clones were obtained with higher productivity in fed-batch culture mode using rich formulated media comparing with lean formulated media. Developed methods may remove the requirements for cell adaptation to production media after cell line development, and relieve the clonality issues associated with changing the culture media. Furthermore, established methods have advantages over traditional approaches, including saving resources and decreasing the time and the effort required to optimize the production process.
引用
收藏
相关论文
共 50 条
  • [1] Rich production media as a platform for CHO cell line development
    Kim, Yong Jae
    Han, Sang Kyul
    Yoon, Seongtae
    Kim, Chan Wha
    AMB EXPRESS, 2020, 10 (01)
  • [2] Development of a CHO cell-free synthetic platform for production of monoclonal antibodies
    Majewska, Natalia
    Martin, Rey
    Moore, Kenneth
    Schmelzer, Albert
    Jewett, Michael
    Roy, Varnika
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [3] High performance CHO cell line development platform for enhanced production of recombinant proteins including difficult-to-express proteins
    Pierre-Alain Girod
    Valérie Le Fourn
    David Calabrese
    Alexandre Regamey
    Deborah Ley
    Nicolas Mermod
    BMC Proceedings, 7 (Suppl 6)
  • [4] Effect of different cell culture media on the production and glycosylation of a monoclonal antibody from a CHO cell line
    Jaeweon Lee
    Uriel Ortega-Rodriguez
    Chikkathur N. Madhavarao
    Tongzhong Ju
    Thomas O’Connor
    Muhammad Ashraf
    Seongkyu Yoon
    Cytotechnology, 2025, 77 (3)
  • [5] Development and evaluation of a new, specially tailored CHO media platform
    Tim F Beckmann
    Christoph Heinrich
    Heino Büntemeyer
    Stefan Northoff
    BMC Proceedings, 7 (Suppl 6)
  • [6] Generation of reference cell lines, media, and a process platform for CHO cell biomanufacturing
    Cordova, Lauren T.
    Dahodwala, Hussain
    Elliott, Kathryn S.
    Baik, Jongyoun
    Odenewelder, Daniel C.
    Nmagu, Douglas
    Skelton, Bradley A.
    Uy, Lisa
    Klaubert, Stephanie R.
    Synoground, Benjamin F.
    Chitwood, Dylan G.
    Dhara, Venkata Gayatri
    Naik, Harnish Mukesh
    Morris, Caitlin S.
    Yoon, Seongkyu
    Betenbaugh, Michael
    Coffman, Jon
    Swartzwelder, Frank
    Gilmeister, Michael
    Harcum, Sarah W.
    Lee, Kelvin H.
    BIOTECHNOLOGY AND BIOENGINEERING, 2023, 120 (03) : 715 - 725
  • [7] Development of serum-free media for a recombinant CHO cell line producing recombinant antibody
    Kim, Do Yun
    Lee, Joon Chul
    Chang, Ho Nam
    Oh, Duk Jae
    ENZYME AND MICROBIAL TECHNOLOGY, 2006, 39 (03) : 426 - 433
  • [8] Metabolic engineering of CHO cells for the development of a robust protein production platform
    Gupta, Sanjeev Kumar
    Srivastava, Santosh K.
    Sharma, Ankit
    Nalage, Vaibhav H. H.
    Salvi, Darshita
    Kushwaha, Hiralal
    Chitnis, Nikhil B.
    Shukla, Pratyoosh
    PLOS ONE, 2017, 12 (08):
  • [9] GPEx® system to increase production of pritumumab in a CHO cell line
    Bleck, Gregory T.
    Gupta, Rishab K.
    Kotlan, Beatrix
    York, Dona
    Glassy, Mark C.
    CANCER RESEARCH, 2014, 74 (19)
  • [10] Process intensification for the production of rituximab by an inducible CHO cell line
    Kahina Mellahi
    Denis Brochu
    Michel Gilbert
    Michel Perrier
    Sven Ansorge
    Yves Durocher
    Olivier Henry
    Bioprocess and Biosystems Engineering, 2019, 42 : 711 - 725